Keyphrases
Meta-analysis
100%
Systematic Meta-analysis
100%
Chinese Patent Medicine
100%
Xiaoyaosan
100%
Polycystic Ovary Syndrome
100%
Confidence Interval
45%
Conventional Medicine
36%
Randomized Controlled Trial
27%
Odds Ratio
27%
Standardized Mean Difference
27%
Pregnancy Rate
27%
Ovulation Rate
27%
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
18%
Fasting Insulin
18%
China
9%
Clinical Trials
9%
Random Effects Model
9%
Fixed Effects Model
9%
Embase
9%
PubMed
9%
Fasting Plasma Glucose
9%
Cochrane Library
9%
Ethnopharmacological Relevance
9%
Journal Databases
9%
Selection Criteria
9%
Metabolic Disorders
9%
Methodological Shortcomings
9%
Complementary Therapies
9%
Adjuvant Therapy
9%
Biomedical Databases
9%
China National Knowledge Infrastructure
9%
Luteinizing Hormone
9%
Follicle-stimulating Hormone
9%
Hormonal Levels
9%
Pooling Effect
9%
Serious Adverse Reaction
9%
Data Pooling
9%
Insulin Model
9%
Women of Reproductive Age
9%
Glycemic Parameters
9%
Total Testosterone
9%
Pharmacology, Toxicology and Pharmaceutical Science
Ovary Polycystic Disease
100%
Randomized Controlled Trial
27%
Insulin Resistance
18%
Clinical Trial
9%
Follitropin
9%
Adverse Event
9%
Random Effects Model
9%
Luteinizing Hormone
9%